V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260014551 | 260019113 | null | null | Curative (C) | null | 2017-09-15 | Cisplatin | null | null | 260030118 | MAP |
| 260014552 | 260009909 | 1.78 | 82.4 | Curative (C) | 2014-02-05 | 2014-02-07 | Gemcitabine + Oxaliplatin | N | N | 260030125 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260014553 | 260014713 | null | 66.8 | Palliative (P) | null | 2015-09-05 | TRASTUZUMAB | null | null | 260030125 | CHOP |
| 260014554 | 260009911 | 1.58 | 66 | Disease modification (D) | 2015-11-04 | 2015-11-04 | FEC 60 or 75 | 02 | N | 260030127 | TRASTUZUMAB |
| 260014555 | 260009914 | 1.79 | 59 | Curative (C) | 2018-02-12 | 2018-02-12 | CYCLOPHOSPHAMIDE + VINORELBINE | 02 | N | 260030140 | BLEOMYCIN + CISPLATIN + VINCRISTINE |
| 260014556 | 260009914 | 1.73 | 47 | Curative (C) | 2015-05-10 | 2017-05-18 | CHOP - 21 days | Y | N | 260030140 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 260014557 | 260009914 | null | 89 | Palliative (P) | 2016-02-24 | 2016-02-24 | Bleomycin + Cisplatin + Vinblastine | N | N | 260030140 | BLEOMYCIN |
| 260014558 | 260009915 | null | 72.3 | Not known (9) | null | 2018-02-18 | Methotrexate High Dose (3g/m2) | null | null | 260000643 | GEMCITABINE + PACLITAXEL |
| 260014559 | 260009915 | null | 73.8 | Curative (C) | 2017-10-05 | 2017-10-08 | CISPLATIN + IFOSFAMIDE + MESNA + VINBLASTINE | N | N | 260000643 | BLEOMYCIN + CISPLATIN + ETOPOSIDE |
| 260014560 | 260009916 | 1.76 | 96 | Disease modification (D) | 2013-10-18 | 2013-10-22 | Carboplatin + Etoposide IV 3 day | 2 | N | 260005528 | RMS 2005 TRIAL |
| 260014561 | 260009917 | 1.72 | 92 | Palliative (P) | 2018-05-29 | 2018-06-08 | Erlotinib | N | N | 260005534 | CARBOPLATIN + ETOPOSIDE |
| 260014562 | 260009919 | 1.83 | null | null | 2017-01-25 | 2017-01-25 | CISPLATIN + EPIRUBICIN | N | null | 260005592 | CARBOPLATIN + ETOPOSIDE |
| 260014563 | 260009919 | 1.63 | 110 | null | 2014-11-04 | 2014-11-15 | CHOP - 21 days | N | N | 260005592 | METHOTREXATE |
| 260014564 | 260009919 | 1.67 | 78.4 | Curative (C) | 2018-03-17 | 2018-03-26 | BLEOMYCIN + CISPLATIN + ETOPOSIDE + PACLITAXEL | 2 | N | 260005592 | IVA |
| 260014565 | 260009919 | 1.8 | 45.5 | Curative (C) | null | 2017-09-14 | ACE (germ cell) | N | N | 260005592 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 260014566 | 260009920 | 1.9 | 72.6 | Palliative (P) | 2018-11-17 | 2018-11-17 | Carboplatin + Etoposide IV 3 day | N | N | 260005973 | GEMCITABINE + TIP |
| 260014567 | 260009922 | 1.48 | 94.2 | Curative (C) | 2018-12-25 | 2018-12-26 | ICE | 2 | N | 260005976 | DOCETAXEL + TRASTUZUMAB |
| 260014568 | 260009923 | 1.59 | null | Not known (9) | 2018-11-22 | 2018-12-03 | Carboplatin 21day + Paclitaxel 7day | 2 | null | 260006047 | METHOTREXATE |
| 260014569 | 260009926 | 1.6 | 82.9 | null | 2018-02-13 | 2018-03-06 | BLEOMYCIN | N | N | 260006047 | ACE (GERM CELL) |
| 260014570 | 260009926 | 1.74 | 67 | Palliative (P) | 2018-03-09 | 2018-03-09 | BOP | 02 | N | 260006047 | OBINUTUZUMAB |
| 260014571 | 260009926 | 1.59 | 61.4 | Curative (C) | 2017-07-24 | 2017-07-25 | CHOP - 21 days | N | N | 260006047 | TRASTUZUMAB |
| 260014572 | 260009926 | 1.7 | 93.5 | Palliative (P) | 2017-02-04 | 2017-02-06 | Gemcitabine + Oxaliplatin | N | N | 260006047 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260014573 | 260009926 | 1.55 | 67.6 | Adjuvant (A) | 2017-08-17 | 2017-08-27 | Hydroxycarbamide | N | N | 260006047 | CYCLOPHOSPHAMIDE |
| 260014574 | 260019395 | 1.71 | 80.9 | Curative (C) | 2017-10-19 | 2017-12-04 | R Chlorambucil | N | null | 260006875 | IVA |
| 260014575 | 260009929 | null | 83.9 | Curative (C) | null | 2019-02-18 | BLEOMYCIN + CISPLATIN + ETOPOSIDE + PACLITAXEL | N | null | 260006996 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260014576 | 260009930 | null | 79 | Disease modification (D) | 2018-01-28 | 2018-04-29 | BLEOMYCIN + CISPLATIN + VINCRISTINE | N | N | 260007052 | GEMCITABINE + OXALIPLATIN |
| 260014577 | 260009931 | null | 78.9 | Curative (C) | 2014-01-03 | 2014-01-03 | CYCLOPHOSPHAMIDE | N | N | 260007113 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260014578 | 260009932 | 1.72 | 76.5 | Curative (C) | 2018-10-10 | 2018-10-15 | METHOTREXATE | N | N | 260007145 | POMB |
| 260014579 | 260009933 | 1.7 | 90 | Palliative (P) | 2018-12-21 | 2019-01-05 | Obinutuzumab | N | N | 260007178 | BLEOMYCIN + CISPLATIN + ETOPOSIDE |
| 260014580 | 260009934 | 1.87 | 69.8 | Curative (C) | 2015-09-11 | 2015-11-01 | EP | N | N | 260007190 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE |
| 260014581 | 260009936 | 1.54 | 117 | Curative (C) | 2015-03-27 | 2015-08-06 | NIVOLUMAB | 02 | N | 260007208 | TRASTUZUMAB |
| 260014582 | 260014721 | null | 65.7 | Palliative (P) | 2014-12-14 | 2014-12-14 | CARBO + THIOTEPA + TOPOTECAN | 02 | N | 260007242 | PEI |
| 260014583 | 260009937 | 1.77 | null | Curative (C) | 2015-08-20 | 2015-08-20 | IVA | N | N | 260007261 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE |
| 260014584 | 260009939 | 1.85 | 68.8 | Adjuvant (A) | 2019-01-06 | 2019-01-06 | BLEOMYCIN + CISPLATIN + ETOPOSIDE | N | N | 260007447 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260014585 | 260009940 | 1.66 | 64.5 | Disease modification (D) | 2016-05-06 | 2016-05-16 | Trastuzumab Subcutaneous | 2 | N | 260007482 | NIVOLUMAB |
| 260014586 | 260014723 | 1.84 | 90 | Palliative (P) | 2016-08-14 | 2016-08-17 | Vinblastine weekly | N | N | 260007493 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260014587 | 260009941 | 1.57 | 56.6 | Palliative (P) | null | 2016-08-21 | CISPLATIN + GEMCITABINE + RITUXIMAB | N | N | 260007508 | METHOTREXATE |
| 260014588 | 260009942 | 1.7 | 94.2 | Curative (C) | 2018-10-05 | 2018-10-17 | DHAP - R | 02 | N | 260007540 | GEMCITABINE + PACLITAXEL |
| 260014589 | 260009943 | 1.75 | 85.4 | Curative (C) | 2014-02-28 | 2014-06-01 | BLEOMYCIN + CISPLATIN + VINCRISTINE | N | N | 260007582 | GEMCITABINE + OXALIPLATIN + PACLITAXEL |
| 260014590 | 260009944 | 1.76 | 81.5 | Palliative (P) | 2016-11-07 | 2016-11-17 | METHOTREXATE + VINCRISTINE | N | N | 260007582 | RMS 2005 TRIAL |
| 260014591 | 260009945 | 1.85 | 86.8 | Curative (C) | 2017-05-15 | 2017-05-21 | BLEOMYCIN | 2 | N | 260007760 | EP |
| 260014592 | 260009946 | 1.63 | 46.2 | Palliative (P) | 2017-06-07 | 2017-06-22 | Methotrexate High Dose (3g/m2) | N | N | 260007834 | CYCLOPHOSPHAMIDE |
| 260014593 | 260009948 | 1.67 | 85.4 | Curative (C) | 2016-06-18 | 2016-06-18 | CVP | N | N | 260007834 | CVP |
| 260014594 | 260009950 | 1.88 | 71.7 | Palliative (P) | 2018-04-30 | 2018-05-01 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | N | N | 260007862 | CISPLATIN + VINORELBINE |
| 260014595 | 260009954 | 1.88 | 88.7 | Palliative (P) | 2018-09-12 | 2018-10-09 | Vinblastine weekly | N | N | 260007889 | BLEOMYCIN + CISPLATIN + VINCRISTINE |
| 260014596 | 260009957 | 1.8 | 61.7 | Disease modification (D) | 2014-05-06 | 2014-05-06 | POMB | 2 | N | 260007890 | VIP |
| 260014597 | 260009963 | 1.67 | null | Disease modification (D) | 2017-12-04 | 2017-12-12 | Bendamustine + Obinutuzumab | N | N | 260007908 | CYCLOPHOSPHAMIDE |
| 260014598 | 260014727 | 1.72 | 102 | Curative (C) | 2018-02-24 | 2018-04-01 | Gemcitabine + Oxaliplatin | Y | N | 260007966 | BLEOMYCIN |
| 260014599 | 260009966 | 1.6 | 102 | Disease modification (D) | 2018-08-19 | 2018-08-20 | BLEOMYCIN | 2 | N | 260008017 | CARBO + THIOTEPA + TOPOTECAN |
| 260014600 | 260009967 | 1.65 | 80.2 | Palliative (P) | 2017-07-18 | 2017-12-10 | IFOSFAMIDE + PACLITAXEL | N | N | 260008025 | BLEOMYCIN + CISPLATIN + VINBLASTINE |